Briggs Morrison insider trades

Open-market stock purchases and sales by Briggs Morrison, Director at Arvinas, Inc, from SEC Form 4 filings since Feb 6, 2017.

Track record: 57% of 7 scored buys are up 5% or more since purchase, averaging +19%.

Recent trades

DateStockTradeValue
Jun 24, 2026ARVN Arvinas, IncBought (not open market)—
Jun 24, 2026ARVN Arvinas, IncBought (not open market)—
Jun 5, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 6, 2026ARVN Arvinas, IncBought$268K

Companies traded

  • ARVN Arvinas, Inc: 3 buys, 7 sales, last Jun 24, 2026
  • CRSP CRISPR Therapeutics AG: other filings, last Jun 5, 2026
  • HOWL Werewolf Therapeutics, Inc: other filings, last Jun 12, 2025
  • CARM Carisma Therapeutics Inc: other filings, last Jun 26, 2024
  • RPTX Repare Therapeutics Inc: 1 buy, last Jun 17, 2024
  • SNDX Syndax Pharmaceuticals Inc: 4 buys, 25 sales, last Feb 7, 2024
  • CDAK Codiak BioSciences, Inc: 1 buy, last Feb 17, 2021
  • NXTC NextCure, Inc: other filings, last Jun 11, 2020

Get free alerts when Briggs Morrison files a new trade →